Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

LA JOLLA PHARMACEUTICAL CO (LJPC) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/01/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/29/2022 SC 13D/A GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in La Jolla Pharmaceutical Co.
08/29/2022 SC 13D GARDNER LEWIS ASSET MANAGEMENT L P reports a 6% stake in La Jolla Pharmaceutical Co.
08/24/2022 SC 13D/A TANG CAPITAL PARTNERS LP reports a 0% stake in La Jolla Pharmaceutical Company
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/23/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/22/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/22/2022 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of La Jolla Pharmaceutical Company",
"Amended and Restated Bylaws of La Jolla Pharmaceutical Company"
08/22/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/22/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/16/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
08/15/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/25/2022 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
07/25/2022 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
07/12/2022 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
07/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/11/2022 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
07/11/2022 425 Form 425 - Prospectuses and communications, business combinations:
07/11/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/02/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
03/09/2022 10-K Annual Report for the period ended December 31, 2021
02/16/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/14/2022 SC 13G/A RTW INVESTMENTS, LP reports a 9.3% stake in La Jolla Pharmaceutical Company
12/02/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/18/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "La Jolla Pharmaceutical Company Announces Share Repurchase Plan"
11/04/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/04/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
11/04/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy